CRU@The Neuro(@NeuroCRU) 's Twitter Profileg
CRU@The Neuro

@NeuroCRU

Clinical Research Unit (CRU) at The Neuro - a leading centre affiliated with McGill, conducting 130 trials/year in all areas of neurology. https://t.co/soFL7yUzjF

ID:1245768416369291264

linkhttp://CRU.McGill.Ca calendar_today02-04-2020 17:42:21

207 Tweets

358 Followers

254 Following

Follow People
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

The Saguenay region of Quebec has the highest prevalence of in the world (1 in 400). Several new on at the CRU are testing -based therapies that, if successful, would offer the first disease modifying treatment. cru.mcgill.ca/nm

The Saguenay region of Quebec has the highest prevalence of #MyotonicDystrophy in the world (1 in 400). Several new #clinicaltrials on #DM1 at the CRU are testing #ASO-based therapies that, if successful, would offer the first disease modifying treatment. cru.mcgill.ca/nm
account_circle
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

Even takes a short break for a once-in-a-lifetime ! Physicians, clinicians, researchers, clinical research coordinators and even patients headed outside to (safely) view the astronomical event.
The Neuro McGill University McGill Office for Science and Society McGill Physics

Even #research takes a short break for a once-in-a-lifetime #eclipse! Physicians, clinicians, researchers, clinical research coordinators and even patients headed outside to (safely) view the astronomical event. @TheNeuro_MNI @mcgillu @McGillOSS @McGillUPhysics
account_circle
The Neuro(@TheNeuro_MNI) 's Twitter Profile Photo

La Journée Lavande 26 Mars est la journée mondiale de sensibilisation à l'épilepsie. L’épilepsie est un trouble neurologique caractérisé par un changement soudain et bref du cerveau qui se manifeste sous forme de crise. En savoir plus buff.ly/4avrMMt

La Journée Lavande 26 Mars est la journée mondiale de sensibilisation à l'épilepsie. L’épilepsie est un trouble neurologique caractérisé par un changement soudain et bref du cerveau qui se manifeste sous forme de crise. En savoir plus buff.ly/4avrMMt
account_circle
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

Health Canada has approved eye-tracking software to assess . An ongoing observational study at the CRU is testing if it could accurately predict score. If successful, more sensitive, real-time biomarkers would be available to clinicians. cru.mcgill.ca/ms.

Health Canada has approved #ETNA eye-tracking software to assess #MS. An ongoing observational study at the CRU is testing if it could accurately predict #EDSS score. If successful, more sensitive, real-time biomarkers would be available to clinicians. cru.mcgill.ca/ms.
account_circle
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

Grande nouvelle! Fiers d'annoncer que l'URC a lancé son tout premier essai de pour une maladie neurologique. Cette étude de sur la avec mutation teste une thérapie par vecteur viral à dose unique. 1er patient dépisté cette semaine! The Neuro

Grande nouvelle! Fiers d'annoncer que l'URC a lancé son tout premier essai de #thérapiegénique pour une maladie neurologique. Cette étude de #phase1 sur la #DFT avec mutation #GRN teste une thérapie par vecteur viral à dose unique. 1er patient dépisté cette semaine! @TheNeuro_MNI
account_circle
Ziv Gan-Or(@ZivGanOr) 's Twitter Profile Photo

Gave a talk this morning at the Royal London hospital about neurogenomics and Precision Medicine in neurodegeneration. On my way back, we went by the old Royal London building where James Parkinson used to work. Thank you Alastair Noyce for the invite!

Gave a talk this morning at the Royal London hospital about neurogenomics and Precision Medicine in neurodegeneration. On my way back, we went by the old Royal London building where James Parkinson used to work. Thank you @predictPD for the invite!
account_circle
Brain Canada(@BrainCanada) 's Twitter Profile Photo

Dr. Viviane Poupon, Brain Canada's President & CEO, highlighted open science's vital role in dementia research at the CCNA-CCNV conference this morning. From a funder's perspective, she outlined ways to leverage it for faster scientific advancement.

Dr. @VivianePoupon, @BrainCanada's President & CEO, highlighted open science's vital role in dementia research at the @ccna_ccnv conference this morning. From a funder's perspective, she outlined ways to leverage it for faster scientific advancement. #OpenScience
account_circle
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

The CRU is now officially part of @MyGreenLab Initiative The Neuro! This program recognizes that scientific research has a heavy reliance on single-use items. Expired items from kits at the CRU will now help train nurses in the simulation program McGill Nursing

The CRU is now officially part of @MyGreenLab Initiative @TheNeuro_MNI! This program recognizes that scientific research has a heavy reliance on single-use items. Expired items from #clinicaltrial kits at the CRU will now help train nurses in the simulation program @McgillNursing
account_circle
The Neuro(@TheNeuro_MNI) 's Twitter Profile Photo

🧠 Calling all Neuroscience Innovators! 🧠 The Neuro – Irv and Helga Cooper Foundation Open Science Prizes are now accepting submissions! Submit your entry and be recognized for your contributions!

account_circle
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

highlights the urgency of supporting brain research. The CRU continues to expand the rare neurological conditions it covers. Brains need you. You can support this research, by directing your gift to clinical trials The Neuro:
mcgill.ca/neuro/donate.

#BrainAwarenessWeek highlights the urgency of supporting brain research. The CRU continues to expand the rare neurological conditions it covers. Brains need you. You can support this research, by directing your gift to clinical trials @TheNeuro_MNI: mcgill.ca/neuro/donate.
account_circle
Dystrophie musculaire Canada(@Action_Musclee) 's Twitter Profile Photo

Saviez-vous que le gouvernement du Canada avait annoncé un financement de 1,5 milliard $ dans le cadre de sa « Stratégie nationale visant les médicaments pour le traitement des maladies rares »? En 2024, nous n'avons toujours pas de stratégie sur les maladies rares au Canada.

Saviez-vous que le gouvernement du Canada avait annoncé un financement de 1,5 milliard $ dans le cadre de sa « Stratégie nationale visant les médicaments pour le traitement des maladies rares »? En 2024, nous n'avons toujours pas de stratégie sur les maladies rares au Canada.
account_circle
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

All should be treatable. Working towards effective therapies is essential. Each year, NeuroCRU adds new conditions to its list of trials, like , , and . Patients deserve the option of accessing investigational treatments.

All #rarediseases should be treatable. Working towards effective therapies is essential. Each year, NeuroCRU adds new conditions to its list of trials, like #MOGAD, #FSHD, #Huntingtons and #CJD. Patients deserve the option of accessing investigational treatments. #RareDiseaseDay
account_circle
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

Almost 60% of CRU staff are . On , we celebrate the expertise + dedication they bring to improving the delivery of and supporting patients who face challenging conditions. They make clinical research happen! The Neuro McGill Nursing Centre universitaire de santé McGill

account_circle
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

Dr. Ron Postuma, a PI at the CRU, is part of an intl group calling for a paradigm shift in classifying . They advocate for a biological model to help identify the disease earlier and better target phenotypes in developing treatments. thelancet.com/journals/laneu…

account_circle
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

The CRU launched its first ever trial into , a neurodegenerative with physical, cognitive + emotional symptoms, diagnosed in the prime of life with only 10-25 year survival. Info: cru.mcgill.ca/mvtdis; [email protected]. The Neuro

account_circle
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

Le Programme de formation sur les troubles neurocognitifs de McGill organise une conférence importante à propos du deuil complexe auquel les aidants sont confrontés alors que leur proche est encore vivant. À ne pas manquer: 31 janvier 13h30 mcgill.ca/x/UHK.

Le Programme de formation sur les troubles neurocognitifs de McGill organise une conférence importante à propos du deuil complexe auquel les aidants sont confrontés alors que leur proche est encore vivant. À ne pas manquer: 31 janvier 13h30 mcgill.ca/x/UHK. #alzheimer
account_circle
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

✨L’équipe de l’URC vous souhaite de joyeuses Fêtes avec vos proches et une nouvelle année remplie de santé, bonheur et prospérité! 🎉 The team at CRU@The Neuro wishes you a joyous holiday season, and a healthy, happy and prosperous new year!✨

account_circle
CRU@The Neuro(@NeuroCRU) 's Twitter Profile Photo

A look back at 2023 at CRU@The Neuro. Plenty of firsts, including the first ever gene therapy in Canada for and trials in new indications for our unit like , , . Also lots of international collabs. Highlights: cru.mcgill.ca/2023review. The Neuro

account_circle